BVS - CIK 0001665988
Bioventus Inc. (BVS) reported net income of $22.73M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $22.73M | +162.9% |
| FY 2024 | -$36.13M | +76.9% |
| FY 2023 | -$156.23M | +1.6% |
| FY 2022 | -$158.70M | -919.1% |
| FY 2021 | $19.38M | +18.1% |
| FY 2020 | $16.41M | +139.5% |
| FY 2019 | $6.85M | - |
Bioventus Inc. (BVS) reported net income of $22.73M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2019 and fiscal 2025, Bioventus Inc.'s net income grew from $6.85M to $22.73M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.